Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
LaFleur Expands Swanson Gold Deposit System, Confirming Strong Continuity with 2.95 g/t Au over 80.00 metres and 2.37 g/t Au over 88.05 metres
Yukon Metals Just Optioned a Sumitomo-Drilled Copper-Gold Project Next to Its Birch Discovery - Here's What's Now in Play in the Yukon
